Albireo Piotroski F Score

ALBO Stock  USD 44.51  0.08  0.18%   
This module uses fundamental data of Albireo Pharma to approximate its Piotroski F score. Albireo Pharma F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Albireo Pharma. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Albireo Pharma financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Please continue to Albireo Pharma Altman Z Score, Albireo Pharma Correlation, Albireo Pharma Valuation, as well as analyze Albireo Pharma Alpha and Beta and Albireo Pharma Hype Analysis.
  
Albireo Pharma Issuance Repayment of Debt Securities is very stable at the moment as compared to the past year. Albireo Pharma reported last year Issuance Repayment of Debt Securities of 10.91 Million. As of 7th of February 2023, Debt to Equity Ratio is likely to grow to 0.07, while Total Debt is likely to drop about 10.4 M. Albireo Pharma Price to Sales Ratio is very stable at the moment as compared to the past year. Albireo Pharma reported last year Price to Sales Ratio of 9.93. As of 7th of February 2023, Sales per Share is likely to grow to 2.59, while PPandE Turnover is likely to drop 67.56.
At this time, it appears that Albireo Pharma's Piotroski F Score is Frail. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
3.0
Piotroski F Score - Frail
1
Current Return On AssetsNegativeFocus
2
Change in Return on AssetsDecreasedFocus
3
Cash Flow Return on AssetsNegativeFocus
4
Current Quality of Earnings (accrual)ImprovingFocus
5
Asset Turnover GrowthDecreaseFocus
6
Current Ratio ChangeIncreaseFocus
7
Long Term Debt Over Assets ChangeLower LeverageFocus
8
Change In Outstending SharesIncreaseFocus
9
Change in Gross MarginNo ChangeFocus

Albireo Pharma Piotroski F Score Drivers

The critical factor to consider when applying the Piotroski F Score to Albireo Pharma is to make sure Albireo is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Albireo Pharma's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Albireo Pharma's financial numbers are properly reported.
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares Diluted18.7 M17.3 M
Significantly Up
Up
Slightly volatile
Weighted Average Shares18.7 M17.3 M
Significantly Up
Up
Slightly volatile
Current Liabilities44 M40.8 M
Significantly Up
Up
Slightly volatile
Total Liabilities122.8 M113.8 M
Significantly Up
Up
Slightly volatile
Gross Margin86.4886.99
Slightly Down
Down
Slightly volatile
Total Debt10.4 M11.5 M
Moderately Down
Up
Slightly volatile
Asset Turnover0.140.16
Fairly Down
Down
Slightly volatile
Current Assets261.1 M242 M
Significantly Up
Up
Slightly volatile
Total Assets293.3 M271.8 M
Significantly Up
Up
Slightly volatile

Albireo Pharma F Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Albireo Pharma's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Albireo Pharma in a much-optimized way.

About Albireo Pharma Piotroski F Score

F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.

Book Value per Share

8.44

Albireo Pharma Book Value per Share is very stable at the moment as compared to the past year. Albireo Pharma reported last year Book Value per Share of 8.22

Albireo Pharma Current Valuation Drivers

We derive many important indicators used in calculating different scores of Albireo Pharma from analyzing Albireo Pharma's financial statements. These drivers represent accounts that assess Albireo Pharma's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Albireo Pharma's important valuation drivers and their relationship over time.
201820192020202120222023 (projected)
Net Income Per Employee(1.18 M)(1.14 M)(1.19 M)(261.77 K)(301.03 K)(324.8 K)
Revenue Per Employee326.67 K175.2 K92.06 K312.15 K358.97 K360.48 K
Average Assets199.19 M172.87 M240.71 M266.95 M307 M331.23 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(41.21 M)(57.32 M)(96.07 M)(19.8 M)(22.77 M)(24.57 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(41.21 M)(57.29 M)(96.08 M)(19.82 M)(17.84 M)(19.25 M)
Earnings before Tax(46.09 M)(62.72 M)(107.63 M)(34.03 M)(30.63 M)(33.04 M)
Average Equity142.23 M105.98 M148.89 M154.69 M177.89 M191.93 M
Enterprise Value120.02 M179.83 M446.4 M196.32 M225.76 M181.22 M
Free Cash Flow(26.85 M)(53.46 M)(101.11 M)(108.02 M)(97.22 M)(99.78 M)
Invested Capital(8.5 M)(2.96 M)1.41 M1.34 M1.21 M1.3 M
Invested Capital Average(5.73 M)(3.27 M)2.73 M(872 K)(784.8 K)(846.76 K)
Market Capitalization293.62 M322.49 M715.59 M449 M516.35 M557.11 M
Tangible Asset Value168.21 M147.81 M268.35 M284.79 M327.51 M353.37 M
Working Capital154.82 M122.88 M236.58 M223.58 M257.12 M277.42 M

About Albireo Pharma Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Albireo Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Albireo Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Albireo Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. Albireo Pharma, Inc. is headquartered in Boston, Massachusetts. Albireo Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 130 people.

Albireo Pharma Investors Sentiment

The influence of Albireo Pharma's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Albireo. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Albireo Pharma's public news can be used to forecast risks associated with investment in Albireo. The trend in average sentiment can be used to explain how an investor holding Albireo can time the market purely based on public headlines and social activities around Albireo Pharma. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Albireo Pharma's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Albireo Pharma's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Albireo Pharma's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Albireo Pharma.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Albireo Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Albireo Pharma's short interest history, or implied volatility extrapolated from Albireo Pharma options trading.

Pair Trading with Albireo Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Albireo Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Albireo Pharma will appreciate offsetting losses from the drop in the long position's value.

Moving together with Albireo Pharma

+0.85KBKB Financial Group Earnings Call TodayPairCorr

Moving against Albireo Pharma

-0.79CVSCVS Health Corp Earnings Call TomorrowPairCorr
The ability to find closely correlated positions to Albireo Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Albireo Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Albireo Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Albireo Pharma to buy it.
The correlation of Albireo Pharma is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Albireo Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Albireo Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Albireo Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Albireo Pharma Altman Z Score, Albireo Pharma Correlation, Albireo Pharma Valuation, as well as analyze Albireo Pharma Alpha and Beta and Albireo Pharma Hype Analysis. Note that the Albireo Pharma information on this page should be used as a complementary analysis to other Albireo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for Albireo Stock analysis

When running Albireo Pharma price analysis, check to measure Albireo Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Albireo Pharma is operating at the current time. Most of Albireo Pharma's value examination focuses on studying past and present price action to predict the probability of Albireo Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Albireo Pharma's price. Additionally, you may evaluate how the addition of Albireo Pharma to your portfolios can decrease your overall portfolio volatility.
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
CEO Directory
Screen CEOs from public companies around the world
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Money Managers
Screen money managers from public funds and ETFs managed around the world
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Is Albireo Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Albireo Pharma. If investors know Albireo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Albireo Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
922.9 M
Quarterly Revenue Growth
1.683
Return On Assets
(0.25) 
Return On Equity
(0.93) 
The market value of Albireo Pharma is measured differently than its book value, which is the value of Albireo that is recorded on the company's balance sheet. Investors also form their own opinion of Albireo Pharma's value that differs from its market value or its book value, called intrinsic value, which is Albireo Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Albireo Pharma's market value can be influenced by many factors that don't directly affect Albireo Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Albireo Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Albireo Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Albireo Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.